Top Markets
Coin of the day
Novartis India Limited Novartis India Limited

Novartis India Limited

NOVARTIND
Rank in Stocks #14311
Novartis India Limited, an Indian healthcare enterprise, provides a diverse... Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.
Share Price
$17.15
Last synced: 2026-08-31
Market Cap
$423.01M
Change (1 day)
4.67%
Change (1 year)
112.68%
Country
IN
Trade Novartis India Limited (NOVARTIND)

Category

Earnings for Novartis India Limited (NOVARTIND)
Earnings in 2026 TTM: 0
According to Novartis India Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Novartis India Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors